For the next two weeks, a digital poster campaign will be featured in London asking the UK public “Could magic mushrooms be medicine?”.
In a groundbreaking development, Australia is to reclassify psilocybin and MDMA to enable prescribing by authorised psychiatrists.
The Psychedelic Access and European Alliance (PAREA) has launched an appeal to European Union institutions and Member States for psychedelic-assisted therapies in Europe.
Canadian non-profit TheraPsil has announced that patients and medical professionals from across Canada will be reaching out to Parliamentarians to raise awareness of the medical benefits...
Colorado has voted to pass the Natural Medicine Health Act (Proposition 122) by 51.4%, which will see the decriminalisation and regulation of the use of psychedelic medicines.
Will Alberta’s new regulatory framework for the delivery of psychedelic therapies pave the way for their integration into the healthcare system, or will it create a...
On November 8, 2022, Colorado citizens will be casting their vote on the Natural Medicine Health Act 2022 which proposes to decriminalise and regulate the use...
In a groundbreaking move for Canada’s regulatory developments around psychedelics, Alberta has announced it will be introducing quality standards into its Mental Health Services Protection Act...
The Microdosing Collective has stated it is committed to a world where sub-perceptible microdosing of psychedelics is legal, accessible and safe.
Psychedelic Health speaks to the founder of the Psychedelic Access and Research European Alliance (PAREA), Tadeusz Hawrot, about how the organisation aims to facilitate discussions around...
